Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis Research Letter

  

Authors:	King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
Title:	Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
Keywords:	leukemia, myeloid, acute; pyrazines; aniline compounds; pyrazine derivative; azoles; pyrrole derivative; cd135 antigen; acute myeloid leukemia; aniline derivative; fms-like tyrosine kinase 3; humans; human; gilteritinib
Journal Title:	Leukemia Research
Volume:	122
ISSN:	0145-2126
Publisher:	Elsevier Ltd
Date Published:	2022-11-01
Start Page:	106929
Language:	English
DOI:	10.1016/j.leukres.2022.106929
PUBMED:	36244178
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140659001&doi=10.1016%2fj.leukres.2022.106929&partnerID=40&md5=a1ad80fa6e1360a2c6ab723638727020
Notes:	Letter -- Export Date: 1 December 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/200486